Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.57 |
| ▸ | DRD4 | P21917 | 4/20 | 0.57 |
| ▸ | DRD3 | P35462 | 4/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethylbenzene SCHEMBL8846975 | 0.75 | DRD2 (0.56) | DRD2DRD4DRD3SLC6A3 | |
| SCHEMBL7437721 | 0.73 | SLC6A3 (1.00) | DRD2DRD4DRD3SLC6A3SLC6A4 | |
| SCHEMBL5994604 | 0.72 | DRD2 (0.58) | DRD2DRD4DRD3SLC6A3 | |
| SCHEMBL7424758 | 0.71 | SLC6A3 (0.57) | DRD2DRD4DRD3SLC6A3CYP1A2 | |
| SCHEMBL9829609 | 0.70 | SLC6A3 (0.79) | DRD2DRD4DRD3SLC6A3CYP1A2 | |
| SCHEMBL9771032 | 0.70 | DRD2 (0.53) | DRD2DRD4DRD3SLC6A3CYP1A2 | |
| Hydrochloric Acid SCHEMBL9771072 | 0.69 | SLC6A3 (0.76) | DRD2DRD4DRD3SLC6A3CYP1A2 | |
| SCHEMBL24676414 | 0.69 | SLC6A3 (0.90) | DRD2DRD4DRD3SLC6A3SLC6A4 | |
| SCHEMBL2498395 | 0.68 | DRD2 (0.59) | DRD2DRD4DRD3SLC6A3CYP2D6 | |
| SCHEMBL9771028 | 0.67 | DRD2 (0.49) | DRD2DRD4DRD3SLC6A3CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0938305-B8 | METHOD OF ALLEVIATING PAIN BY MEANS OF COMBINING TRAMADOL WITH AN NMDA ANTAGONIST | ENDO PHARMACEUTICALS INC (US) | 2005-10-19 | — | — | EP | disclosed |
| US-6043244-A | Method and composition for treating migraine | ALGOS PHARMACEUTICAL CORPORATION (US) | 2000-03-28 | — | — | US | disclosed |
| EP-0942752-A1 | ANTICONVULSANT CONTAINING COMPOSITION FOR TREATING NEUROPATHIC PAIN | Algos Pharmaceutical Corporation (US) | 1999-09-22 | — | — | EP | disclosed |
| EP-0938305-A2 | METHOD OF ALLEVIATING PAIN BY MEANS OF COMBINING TRAMADOL WITH AN NMDA ANTAGONIST | Algos Pharmaceutical Corporation (US) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998017268-A2 | METHOD OF ALLEVIATING PAIN BY MEANS OF COMBINING TRAMADOL WITH AN NMDA ANTAGONIST | ALGOS PHARMACEUTICAL CORPORATION (US) | 1998-04-30 | — | — | WO | disclosed |
| WO-1998007447-A1 | ANTICONVULSANT CONTAINING COMPOSITION FOR TREATING NEUROPATHIC PAIN | ALGOS PHARMACEUTICAL CORPORATION (US) | 1998-02-26 | — | — | WO | disclosed |